Stocks and Investing
Stocks and Investing
Fri, May 10, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, May 9, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Geoff Meacham Maintained (BIIB) at Hold with Decreased Target to $245 on, May 9th, 2019
Geoff Meacham of Barclays, Maintained "Biogen Inc." (BIIB) at Hold with Decreased Target from $250 to $245 on, May 9th, 2019.
Geoff has made no other calls on BIIB in the last 4 months.
There are 12 other peers that have a rating on BIIB. Out of the 12 peers that are also analyzing BIIB, 10 agree with Geoff's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Carter Gould of "UBS" Downgraded from Strong Buy to Hold on, Friday, March 22nd, 2019
- Robyn Karnauskas of "Citigroup" Downgraded from Strong Buy to Hold and Decreased Target to $230 on, Friday, March 22nd, 2019
- Salim Syed of "Mizuho" Downgraded from Strong Buy to Hold and Decreased Target to $235 on, Friday, March 22nd, 2019
- Sumant Kulkarni of "Canaccord Genuity" Downgraded from Strong Buy to Hold and Decreased Target to $275 on, Friday, March 22nd, 2019
- Matt Phipps of "William Blair" Downgraded from Buy to Hold on, Thursday, March 21st, 2019
- Steve Chesney of "Atlantic Equities" Downgraded from Buy to Hold on, Thursday, March 21st, 2019
- Alethia Young of "Cantor Fitzgerald" Downgraded from Buy to Hold on, Thursday, March 21st, 2019
- Adnan Butt of "Guggenheim" Downgraded from Strong Buy to Hold and Decreased Target to $325 on, Friday, February 22nd, 2019
- Ian Somaiya of "BMO Capital" Initiated at Hold and Held Target at $322 on, Friday, February 22nd, 2019
- Thomas Shrader of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $346 on, Thursday, February 21st, 2019
These are the ratings of the 2 analyists that currently disagree with Geoff
- Christopher Marai of "Nomura" Maintained at Strong Buy with Decreased Target to $320 on, Friday, March 22nd, 2019
- Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Sell on, Friday, March 22nd, 2019